Assembly Biosciences ASMB
NASDAQ ASMB
$23.40 -0.08 (-0.34%)
As of: Sep 30, 2026 · 10:02 AM EDT

Assembly Biosciences (ASMB) Debt Ratio (2010 - 2011)

Updated

Assembly Biosciences' (ASMB) Debt Ratio was 0.11 for Q2 2011.

Analysis

Assembly Biosciences (ASMB) Debt Ratio (2010 - 2011) Analysis & Trends

For FY2010, Debt Ratio at Assembly Biosciences was 0.17.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Assembly Biosciences 468.67 Mn -558.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 0.11
Dec 31, 2010 0.17
API Access

Assembly Biosciences Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ASMB&period=max&api_key=YOUR_API_KEY